Ledger.Open graph →

SEC Form D · filed June 12, 2020

Glympse Bio, Inc

Offering

$45.0M

Sold

$26.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Amy Schulman · Cambridge, MADirector George Zachary · Cambridge, MADirector Caroline Loew · Cambridge, MAExec · Director Wendy W. Adamovich · Cambridge, MAExec Steve Kafka · Cambridge, MADirector Francis Cuss · Cambridge, MADirector Theresia Gouw · Cambridge, MADirector Stanley Lapidus · Cambridge, MADirector Robert Langer · Cambridge, MADirector Jordan Wan · Dover, DEDirector John Wagner · LOS ANGELES, CADirector Monika Mantilla · Coral Gables, FLDirector Tero R. Kosonen · VANCOUVER, British Columbia, CanadaExec Janice Price · LOS ANGELES, CAExec · Director Jeff W. Wilson · Vancouver, British Columbia, CanadaDirector Stephen Fitzgerald · Concord, NHDirector John Wenger · VANCOUVER, British Columbia, CanadaDirector Stephen Carnes · Winter Park, FLDirector Tracey Dawson · Cambridge, MAExec Tracy E. Watkins · WELLSBORO, PADirector Thomas L. Rudy, Jr · WELLSBORO, PADirector Clark S. Frame · WELLSBORO, PAExec · Director Robert G. Loughery · WELLSBORO, PADirector Shelley L. D'Haene · WELLSBORO, PADirector Aaron K. Singer · WELLSBORO, PADirector Susan E. Hartley · WELLSBORO, PADirector Stephen M. Dorwart · WELLSBORO, PADirector Blair T. Rush · WELLSBORO, PAExec Tracey Dawson · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗